A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications.

Frontiers in Cell and Developmental Biology
Furong QinMin Luo

Abstract

Faced with the challenges posed by infectious diseases and cancer, nucleic acid vaccines present excellent prospects in clinical applications. Compared with traditional vaccines, nucleic acid vaccines have the characteristics of high efficiency and low cost. Therefore, nucleic acid vaccines have potential advantages in disease prevention and treatment. However, the low immunogenicity and instability of nucleic acid vaccines have limited their development. Therefore, a large number of studies have been conducted to improve their immunogenicity and stability by improving delivery methods, thereby supporting progress and development for clinical applications. This article mainly reviews the advantages, disadvantages, mechanisms, delivery methods, and clinical applications of nucleic acid vaccines.

References

Mar 23, 1990·Science·J A WolffP L Felgner
Jul 1, 1990·Molecular and Cellular Biology·D Munroe, A Jacobson
Jul 1, 1990·Trends in Biochemical Sciences·M Wickens
Sep 1, 1967·Proceedings of the National Academy of Sciences of the United States of America·A K FieldM R Hilleman
Jun 1, 1980·Microbiological Reviews·A K Banerjee
Feb 1, 1996·The Journal of Infectious Diseases·J J DonnellyM A Liu
Aug 1, 1996·The Journal of Experimental Medicine·D BoczkowskiE Gilboa
Feb 10, 1997·Human Gene Therapy·G MorD M Klinman
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·G HartmannA M Krieg
Nov 26, 1999·Gene·Z Dominski, W F Marzluff
Dec 29, 2000·Nature·H HemmiS Akira
Apr 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M BauerG B Lipford
Sep 20, 2001·Current Pharmaceutical Design·W W LeitnerJ Thalhamer
Jan 9, 2003·Expert Opinion on Biological Therapy·Michael A MorseH Kim Lyerly
Mar 5, 2003·Annual Review of Immunology·Drew Pardoll
Aug 30, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zhi-Ying ChenMark A Kay
Sep 10, 2003·Gene Therapy·H WürteleP Chartrand
Dec 6, 2003·Journal of Leukocyte Biology·Gérald J Prud'homme
Jan 20, 2004·The Journal of Biological Chemistry·Katalin KarikóDrew Weissman
Jan 30, 2004·Nature Structural & Molecular Biology·Roy Parker, Haiwei Song
Jan 31, 2004·Current Opinion in Allergy and Clinical Immunology·Troy R Torgerson, Hans D Ochs
Feb 10, 2004·European Journal of Immunology·Birgit ScheelSteve Pascolo
Feb 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Regina M KoflerChristian W Mandl
Feb 21, 2004·Science·Sandra S DieboldCaetano Reis e Sousa
Sep 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·E Ashley MosemanWei Chen
Oct 14, 2004·Immunology and Cell Biology·Nikolai Petrovsky, Julio César Aguilar
Nov 13, 2004·The Journal of Gene Medicine·Gérald J Prud'homme
Jul 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·John J DonnellyMargaret A Liu
Nov 15, 2005·Nature Structural & Molecular Biology·Akio YamashitaAnn-Bin Shyu
May 5, 2006·Proceedings of the National Academy of Sciences of the United States of America·Patrizia StoitznerNikolaus Romani
Jan 26, 2007·Pharmaceutical Research·Weijun Li, Francis C Szoka

❮ Previous
Next ❯

Software Mentioned

LEISHDNAVAX

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Expert Opinion on Emerging Drugs
Leisha A Emens
Boletín médico del Hospital Infantil de México
Leticia A Barajas-Nava
Human Vaccines & Immunotherapeutics
Yorgo C ZahlanieGhassan S Dbaibo
Nature Reviews. Cancer
Mansi SaxenaNina Bhardwaj
© 2021 Meta ULC. All rights reserved